Cytotheryx Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Latest Deal Amount
  • $60M

  • Investors
  • 6

Cytotheryx General Information

Description

Developer of a therapeutic platform designed to develop cell-based therapies for acute, chronic, and rare liver diseases. The company offers a proprietary bio-incubator that produces scalable, clinically relevant primary human hepatocytes and supports programs in bioartificial liver assist devices, hepatocyte-cell transplant therapy, hepatitis research, gene therapy testing, and preclinical safety and toxicology testing, enabling researchers and healthcare providers to advance effective treatments for liver-related conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2112 15th Street North West
  • Rochester, MN 55901
  • United States
+1 (877)
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 2112 15th Street North West
  • Rochester, MN 55901
  • United States
+1 (877)

Cytotheryx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytotheryx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 12-Jan-2026 $60M In Progress Generating Revenue
6. Seed Round 01-Mar-2025 Completed Generating Revenue
5. Seed Round 30-Aug-2024 Completed Generating Revenue
4. Seed Round 31-Mar-2023 Completed Generating Revenue
3. Seed Round 01-Aug-2021 Completed Startup
2. Angel (individual) 01-Jan-2020 Completed Startup
1. Joint Venture 21-Dec-2018 Completed Startup
To view Cytotheryx’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cytotheryx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a therapeutic platform designed to develop cell-based therapies for acute, chronic, and rare liver diseases
Biotechnology
Rochester, MN
15 As of 2026

Newton, MA
 

Tualatin, OR
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cytotheryx Competitors (6)

One of Cytotheryx’s 6 competitors is Satellite Bio, a Venture Capital-Backed company based in Newton, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Satellite Bio Venture Capital-Backed Newton, MA
Yecuris Private Equity-Backed Tualatin, OR
Egenesis Venture Capital-Backed Cambridge, MA
Morphocell Technologies Venture Capital-Backed Laval, Canada
HepaTx Venture Capital-Backed Palo Alto, CA
To view Cytotheryx’s complete competitors history, request access »

Cytotheryx Patents

Cytotheryx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260354358-A1 Methods and materials for the conditional hepatic expression of transgenes in mammalian bioincubators Pending 07-Oct-2022
WO-2024077255-A1 Methods and materials for the conditional hepatic expression of transgenes in mammalian bioincubators Inactive 07-Oct-2022
CA-3238170-A1 Methods of producing and using human hepatocytes and related compositions Pending 12-Nov-2021
EP-4429457-A1 Methods of producing and using human hepatocytes and related compositions Pending 12-Nov-2021
EP-4429457-A4 Methods of producing and using human hepatocytes and related compositions Pending 12-Nov-2021 A61K35/407
To view Cytotheryx’s complete patent history, request access »

Cytotheryx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytotheryx Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Children's Minnesota Corporation Minority
FIN Capital Angels Angel Group Minority
Hill Capital Corporation Growth/Expansion Minority
Austin Area Angels Angel Group Minority
Mayo Clinic Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

Cytotheryx Acquisitions (1)

Cytotheryx’s most recent deal was a Merger/Acquisition with Ambys Medicines. The deal was made on 23-Feb-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ambys Medicines 23-Feb-2023 Merger/Acquisition Drug Discovery
To view Cytotheryx’s complete acquisitions history, request access »

Cytotheryx FAQs

  • When was Cytotheryx founded?

    Cytotheryx was founded in 2018.

  • Where is Cytotheryx headquartered?

    Cytotheryx is headquartered in Rochester, MN.

  • What is the size of Cytotheryx?

    Cytotheryx has 15 total employees.

  • What industry is Cytotheryx in?

    Cytotheryx’s primary industry is Biotechnology.

  • Is Cytotheryx a private or public company?

    Cytotheryx is a Private company.

  • What is the current valuation of Cytotheryx?

    The current valuation of Cytotheryx is .

  • What is Cytotheryx’s current revenue?

    The current revenue for Cytotheryx is .

  • How much funding has Cytotheryx raised over time?

    Cytotheryx has raised $26.5M.

  • Who are Cytotheryx’s investors?

    Children's Minnesota, FIN Capital Angels, Hill Capital Corporation, Austin Area Angels, and Mayo Clinic are 5 of 6 investors who have invested in Cytotheryx.

  • Who are Cytotheryx’s competitors?

    Satellite Bio, Yecuris, Egenesis, Morphocell Technologies, and HepaTx are some of the 6 competitors of Cytotheryx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process